Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VI. 1-Formylisoquinoline derivatives bearing additional ring substituents, with notes on mechanism of action.
D000818:Animals; D002277:Carcinoma / Q000188:drug therapy; D002474:Cell-Free System; D055598:Chemical Phenomena; D002621:Chemistry; D004247:DNA / Q000096:biosynthesis; D007546:Isoquinolines; D007939:Leukemia L1210 / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011725:Pyridines; D012513:Sarcoma, Experimental / Q000188:drug therapy; D013882:Thiosemicarbazones / Q000138:chemical synthesis* / Q000627:therapeutic use*
D007546:Isoquinolines; D011725:Pyridines; D013882:Thiosemicarbazones; D004247:DNA